CStone Pharmaceuticals

CSPHF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$270-$107$16-$158
Dep. & Amort.$0$26$24$29
Deferred Tax$0$0$0$0
Stock-Based Comp.-$2-$7$5$11
Change in WC$0-$48-$118-$62
Other Non-Cash$272-$19-$114-$68
Operating Cash Flow$0-$156-$187-$248
Investing Activities
PP&E Inv.$0$0$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$150-$98$222
Investing Cash Flow$0-$150-$98$222
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$23-$35$123
Financing Cash Flow$0$23-$35$123
Forex Effect$0-$7$3-$6
Net Chg. in Cash$0$0-$159$45
Supplemental Information
Beg. Cash$0$0-$159$45
End Cash$0$0-$159$45
Free Cash Flow$0-$156-$187-$248
CStone Pharmaceuticals (CSPHF) Financial Statements & Key Stats | AlphaPilot